Loss of Response to Anti-TNFs: Definition, Epidemiology, and Management.

Volume: 7, Issue: 1
Published: Jan 7, 2016
Abstract
Tumor necrosis factor-α (TNFα) antagonists have advanced the management of inflammatory bowel diseases patients leading to an improvement of patient's quality of life with the reduction of number of surgeries and hospitalizations. Despite these advances, many patients do not respond to the induction therapy (primary non-response-PNR) or lose response during the treatment (secondary loss of response-LOR). In this paper we will provide an overview...
Paper Details
Title
Loss of Response to Anti-TNFs: Definition, Epidemiology, and Management.
Published Date
Jan 7, 2016
Volume
7
Issue
1
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.